VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
semaglutide우선순위 낮음근거 검토기타

LITERATURE DETAIL · PMID 42493728

Impact of semaglutide on cognitive function in patients with type 2 diabetes and mild cognitive impairment: a 24-month observational study.

Impact of semaglutide on cognitive function in patients with type 2 diabetes and mild cognitive impairment: a 24-month observational study.

저자
Giuliano Cassataro, Silvia Scriffignano, Giulio Geraci, Giuseppa Augello, Maria Angela Grasso, Maria Enza D'Ippolito
저널
Internal and emergency medicine
공개일
2026 Jul 23
연구 유형
기타
DOI
10.1007/s11739-026-04468-x

문헌 요약

Type 2 diabetes mellitus (T2DM) is associated with an increased risk of mild cognitive impairment (MCI) and dementia. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) provide cardiovascular and metabolic benefits, and emerging data suggest neurocognitive effects. We conducted a 24-month prospective observational study of 72 adults (≥ 50 years) with T…

PV 검토 포인트

누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.

PubMed에서 원문 정보 보기